Single-Domain Antibodies as Potent Inhibitors of Clinically Relevant β-Lactamases in Multidrug-Resistant Bacteria
Paloma Osset-Trénor, Markus Proft, Amparo Pascual‐Ahuir
This study identifies two single-domain antibodies that inhibit multiple clinically relevant β-lactamases, with one showing broad activity against several resistance enzymes.
Frontiers in Microbiology · Jun 10, 2026Peer-reviewedMicrobiology